Deborah Johnson
Hematology & Oncology · Baton Rouge, LANPI 1902809692
Payments from drug & device makers
Across 176 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$481
- E.r. Squibb & Sons, L.L.C.$463
- Novartis$305
- Amgen$281
- Pharmacyclics LLC, An Abbvie Company$188
- Bristol Myers Squibb$166
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,07895%
- Education$1505%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 31 | $481 |
| E.r. Squibb & Sons, L.L.C. | 27 | $463 |
| Novartis | 17 | $305 |
| Amgen | 13 | $281 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $188 |
| Bristol Myers Squibb | 10 | $166 |
| Ipsen Biopharmaceuticals, Inc | 6 | $140 |
| Lilly USA, LLC | 9 | $135 |
| AstraZeneca | 8 | $130 |
| Valeritas, Inc. | 1 | $120 |
| Eisai Inc. | 6 | $97 |
| Bayer | 5 | $82 |
| Tesaro, Inc. | 3 | $70 |
| Pfizer | 4 | $67 |
| Puma Biotechnology, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Incyte Corporation | 3 | $41 |
| Gilead | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Astellas Pharma US Inc | 2 | $30 |
| Genentech USA, Inc. | 2 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Seagen Inc. | 2 | $23 |
| Genmab U.S., Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Sanofi | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Pharmaessentia USA Corporation | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $14 |
| Clovis Oncology, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,229 in reported general payments places this provider in the 30th percentile of 183 hematology & oncology providers in Louisiana.
Other hematology & oncology in Baton Rouge
- Hana SafahBaton Rouge$3.8M
- Nakhle SabaBaton Rouge$2.4M
- Victor LinBaton Rouge$2.3M
- Marshall StaggBaton Rouge$1.6M
- William VarnadoBaton Rouge$648K
- Andrew DalovisioBaton Rouge$389K
- Sobia OzairBaton Rouge$378K
- Sanjay JunejaBaton Rouge$346K
- Derrick SpellBaton Rouge$128K
- Christopher McCanlessBaton Rouge$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.